The GLP-1 receptors (GLP-1R) are expressed throughout the brain, and its signaling has been recognized to exert neuroprotective and neurotrophic effects in various experimental models of neurodegenerative diseases, including Alzheimer's disease, Parkinson’s disease, ALS, and ischemic brain injury [71]. Here, GLP1R is linked to amyotrophic lateral sclerosis.